Evidence map›Paper›PMID 24829566›Full record

ReviewFrontiers in immunology2014

Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis.

Garima Chouhan, Mohammad Islamuddin, Dinkar Sahal, Farhat Afrin

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Anti-leishmanial activity ofParasite epidemiology and control · 2022
    Article
  5. Article
  6. Fabrication and Evaluation of W/O Emulsion Loaded withAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Development of a Fluorescent Assay to Search New Drugs Using Stable tdTomato-Frontiers in cellular and infection microbiology · 2021
    Article
  12. Review
  13. Article
  14. Efficacy of FourMedicines (Basel, Switzerland) · 2018
    Article
  15. Article
  16. Article
  17. Antileishmanial and immunomodulatory potential ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2017
    Article
  18. Article
  19. Parasite Killing ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Garima ChouhanParasite Immunology Laboratory, Department of Biotechnology, Jamia Hamdard (Hamdard University) , New Delhi , India.
Mohammad IslamuddinParasite Immunology Laboratory, Department of Biotechnology, Jamia Hamdard (Hamdard University) , New Delhi , India.
Dinkar SahalMalaria Group, International Centre for Genetic Engineering and Biotechnology , New Delhi , India.
Farhat AfrinParasite Immunology Laboratory, Department of Biotechnology, Jamia Hamdard (Hamdard University) , New Delhi , India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a pestilent affliction that importunately needs better therapeutics necessitated by the absence of effective vaccine, emergence as HIV co-infection, and the dread of debilitating chemotherapy. The Leishmania parasites incapacitate host macrophages by preventing the formation of phagolysosomes, impeding antigen presentation to T cells, leading to suppression of cell-mediated immunity. An ideal approach to cure leishmaniasis includes administration of antileishmanial compounds that can concomitantly establish an effective Th1 response via restoration of requisite signaling between macrophages and T cells, for subsequent activation of macrophages to eliminate intracellular amastigotes. Plants have provided an opulent treasure of biomolecules that have fueled the discovery of antileishmanial drugs. Modulation of immune functions using medicinal plants and their products has emerged as an effective therapeutic strategy. Herein, we review the plant extracts and natural products that have resulted in therapeutic polarization of host immunity to cure leishmaniasis. These immunostimulatory phytochemicals as source of potential antileishmanials may provide new strategies to combat leishmaniasis, alone or as adjunct modality.

Indexed as

antileishmanialimmunomodulatorsleishmaniasismedicinal plantsphytochemicals

Identifiers

PMID24829566
PMCPMC4017133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.